Sept 18 (Reuters) - Tetra Bio Pharma Inc
* Tetra Bio-Pharma getting ready to file a Clinical Trial Application to initiate Phase 3 clinical trial on terminal cancer patients in the coming weeks
* Tetra Bio Pharma - with filing of Clinical Trial Application, co expects to be on time with previously announced schedule with development of PPP001
* Tetra Bio Pharma Inc - restructured its investors and public relation functions to integrate them with marketing and communication functions
* Tetra Bio Pharma Inc - Edward Miller is leaving corporation effective as of Sept 18 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.